{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:11:52Z","timestamp":1791288712377,"version":"4.3.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,11]],"date-time":"2014-10-11T00:00:00Z","timestamp":1412985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12977-014-0089-5","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T09:20:42Z","timestamp":1412932842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity"],"prefix":"10.1186","volume":"11","author":[{"given":"Yudi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ballington L","family":"Kinlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiujia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany M","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,11]]},"reference":[{"key":"89_CR1","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1098\/rstb.2008.0185","volume":"364","author":"MH Malim","year":"2009","unstructured":"Malim MH: APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci. 2009, 364: 675-687. 10.1098\/rstb.2008.0185.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"89_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature01707","volume":"424","author":"H Zhang","year":"2003","unstructured":"Zhang H, Yang B, Pomerantz RJ, Zhang C, Arunachalam SC, Gao L: The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature. 2003, 424: 94-98. 10.1038\/nature01707.","journal-title":"Nature"},{"key":"89_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","volume":"114","author":"R Mariani","year":"2003","unstructured":"Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, Munk C, Nymark-McMahon H, Landau NR: Species-Specific Exclusion of APOBEC3G from HIV-1 Virions by Vif. Cell. 2003, 114: 21-31. 10.1016\/S0092-8674(03)00515-4.","journal-title":"Cell"},{"key":"89_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature01709","volume":"424","author":"B Mangeat","year":"2003","unstructured":"Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D: Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature. 2003, 424: 99-103. 10.1038\/nature01709.","journal-title":"Nature"},{"key":"89_CR5","doi-asserted-by":"crossref","unstructured":"Lecossier D, Bouchonnet F, Clavel F, Hance AJ: Hypermutation of HIV-1 DNA in the absence of the Vif protein.Science 2003, 300:1112.,","DOI":"10.1126\/science.1083338"},{"key":"89_CR6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","volume":"113","author":"RS Harris","year":"2003","unstructured":"Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, Neuberger MS, Malim MH: DNA deamination mediates innate immunity to retroviral infection. Cell. 2003, 113: 803-809. 10.1016\/S0092-8674(03)00423-9.","journal-title":"Cell"},{"key":"89_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1126\/science.3497453","volume":"237","author":"AG Fisher","year":"1987","unstructured":"Fisher AG, Ensoli B, Ivanoff L, Chamberlain M, Petteway S, Ratner L, Gallo RC, Wong-Staal F: The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science. 1987, 237: 888-893. 10.1126\/science.3497453.","journal-title":"Science"},{"key":"89_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/328728a0","volume":"328","author":"K Strebel","year":"1987","unstructured":"Strebel K, Daugherty D, Clouse K, Cohen D, Folks T, Martin MA: The HIV 'A' (sor) gene product is essential for virus infectivity. Nature. 1987, 328: 728-730. 10.1038\/328728a0.","journal-title":"Nature"},{"key":"89_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature00939","volume":"418","author":"AM Sheehy","year":"2002","unstructured":"Sheehy AM, Gaddis NC, Choi JD, Malim MH: Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature. 2002, 418: 646-650. 10.1038\/nature00939.","journal-title":"Nature"},{"key":"89_CR10","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.cub.2003.10.034","volume":"13","author":"SG Conticello","year":"2003","unstructured":"Conticello SG, Harris RS, Neuberger MS: The Vif protein of HIV triggers degradation of the human antiretroviral DNA deaminase APOBEC3G. Curr Biol. 2003, 13: 2009-2013. 10.1016\/j.cub.2003.10.034.","journal-title":"Curr Biol"},{"key":"89_CR11","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1128\/JVI.78.4.2072-2081.2004","volume":"78","author":"B Liu","year":"2004","unstructured":"Liu B, Yu X, Luo K, Yu Y, Yu XF: Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. J Virol. 2004, 78: 2072-2081. 10.1128\/JVI.78.4.2072-2081.2004.","journal-title":"J Virol"},{"key":"89_CR12","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/nm946","volume":"9","author":"M Marin","year":"2003","unstructured":"Marin M, Rose KM, Kozak SL, Kabat D: HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med. 2003, 9: 1398-1403. 10.1038\/nm946.","journal-title":"Nat Med"},{"key":"89_CR13","doi-asserted-by":"publisher","first-page":"7792","DOI":"10.1074\/jbc.M313093200","volume":"279","author":"A Mehle","year":"2004","unstructured":"Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D: Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. J Biol Chem. 2004, 279: 7792-7798. 10.1074\/jbc.M313093200.","journal-title":"J Biol Chem"},{"key":"89_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/nm945","volume":"9","author":"AM Sheehy","year":"2003","unstructured":"Sheehy AM, Gaddis NC, Malim MH: The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med. 2003, 9: 1404-1407. 10.1038\/nm945.","journal-title":"Nat Med"},{"key":"89_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S1097-2765(03)00353-8","volume":"12","author":"K Stopak","year":"2003","unstructured":"Stopak K, de Noronha C, Yonemoto W, Greene WC: HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell. 2003, 12: 591-601. 10.1016\/S1097-2765(03)00353-8.","journal-title":"Mol Cell"},{"key":"89_CR16","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1126\/science.1089591","volume":"302","author":"X Yu","year":"2003","unstructured":"Yu X, Yu Y, Liu B, Luo K, Kong W, Mao P, Yu XF: Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 2003, 302: 1056-1060. 10.1126\/science.1089591.","journal-title":"Science"},{"key":"89_CR17","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1101\/gad.1249904","volume":"18","author":"A Mehle","year":"2004","unstructured":"Mehle A, Goncalves J, Santa-Marta M, McPike M, Gabuzda D: Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 2004, 18: 2861-2866. 10.1101\/gad.1249904.","journal-title":"Genes Dev"},{"key":"89_CR18","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1101\/gad.1250204","volume":"18","author":"Y Yu","year":"2004","unstructured":"Yu Y, Xiao Z, Ehrlich ES, Yu X, Yu XF: Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 2004, 18: 2867-2872. 10.1101\/gad.1250204.","journal-title":"Genes Dev"},{"key":"89_CR19","doi-asserted-by":"publisher","first-page":"18573","DOI":"10.1074\/jbc.C500082200","volume":"280","author":"M Kobayashi","year":"2005","unstructured":"Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T: Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. J Biol Chem. 2005, 280: 18573-18578. 10.1074\/jbc.C500082200.","journal-title":"J Biol Chem"},{"key":"89_CR20","doi-asserted-by":"publisher","first-page":"11444","DOI":"10.1073\/pnas.0502440102","volume":"102","author":"K Luo","year":"2005","unstructured":"Luo K, Xiao Z, Ehrlich E, Yu Y, Liu B, Zheng S, Yu XF: Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G. Proc Natl Acad Sci U S A. 2005, 102: 11444-11449. 10.1073\/pnas.0502440102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"89_CR21","doi-asserted-by":"publisher","first-page":"8656","DOI":"10.1128\/JVI.00767-08","volume":"82","author":"BJ Stanley","year":"2008","unstructured":"Stanley BJ, Ehrlich ES, Short L, Yu Y, Xiao Z, Yu XF, Xiong Y: Structural insight into the human immunodeficiency virus Vif SOCS box and its role in human E3 ubiquitin ligase assembly. J Virol. 2008, 82: 8656-8663. 10.1128\/JVI.00767-08.","journal-title":"J Virol"},{"key":"89_CR22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/nar\/gkp1009","volume":"38","author":"G Mercenne","year":"2010","unstructured":"Mercenne G, Bernacchi S, Richer D, Bec G, Henriet S, Paillart JC, Marquet R: HIV-1 Vif binds to APOBEC3G mRNA and inhibits its translation. Nucleic Acids Res. 2010, 38: 633-646. 10.1093\/nar\/gkp1009.","journal-title":"Nucleic Acids Res"},{"key":"89_CR23","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1128\/JVI.77.21.11398-11407.2003","volume":"77","author":"S Kao","year":"2003","unstructured":"Kao S, Khan MA, Miyagi E, Plishka R, Buckler-White A, Strebel K: The Human Immunodeficiency Virus Type 1 Vif Protein Reduces Intracellular Expression and Inhibits Packaging of APOBEC3G (CEM15), a Cellular Inhibitor of Virus Infectivity. J Virol. 2003, 77: 11398-11407. 10.1128\/JVI.77.21.11398-11407.2003.","journal-title":"J Virol"},{"key":"89_CR24","doi-asserted-by":"publisher","first-page":"8765","DOI":"10.1074\/jbc.M409309200","volume":"280","author":"M Santa-Marta","year":"2005","unstructured":"Santa-Marta M, da Silva FA, Fonseca AM, Goncalves J: HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation. J Biol Chem. 2005, 280: 8765-8775. 10.1074\/jbc.M409309200.","journal-title":"J Biol Chem"},{"key":"89_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jmb.2011.03.058","volume":"410","author":"E Britan-Rosich","year":"2011","unstructured":"Britan-Rosich E, Nowarski R, Kotler M: Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif. J Mol Biol. 2011, 410: 1065-1076. 10.1016\/j.jmb.2011.03.058.","journal-title":"J Mol Biol"},{"key":"89_CR26","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1074\/jbc.M112.421875","volume":"288","author":"Y Feng","year":"2013","unstructured":"Feng Y, Love RP, Chelico L: HIV-1 Vif alters processive single-stranded DNA scanning of the retroviral restriction factor APOBEC3G. J Biol Chem. 2013, 288: 6083-6094. 10.1074\/jbc.M112.421875.","journal-title":"J Biol Chem"},{"key":"89_CR27","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1128\/JVI.02587-12","volume":"87","author":"K Gillick","year":"2013","unstructured":"Gillick K, Pollpeter D, Phalora P, Kim EY, Wolinsky SM, Malim MH: Suppression of HIV-1 Infection by APOBEC3 Proteins in Primary Human CD4+ T Cells Is Associated with Inhibition of Processive Reverse Transcription as Well as Excessive Cytidine Deamination. J Virol. 2013, 87: 1508-1517. 10.1128\/JVI.02587-12.","journal-title":"J Virol"},{"key":"89_CR28","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1128\/JVI.01925-10","volume":"85","author":"Y Wang","year":"2011","unstructured":"Wang Y, Shao Q, Yu X, Kong W, Hildreth JE, Liu B: N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination. J Virol. 2011, 85: 4510-4519. 10.1128\/JVI.01925-10.","journal-title":"J Virol"},{"key":"89_CR29","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1073\/pnas.0307713101","volume":"101","author":"HP Bogerd","year":"2004","unstructured":"Bogerd HP, Doehle BP, Wiegand HL, Cullen BR: A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor. Proc Natl Acad Sci U S A. 2004, 101: 3770-3774. 10.1073\/pnas.0307713101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"89_CR30","doi-asserted-by":"publisher","first-page":"14481","DOI":"10.1074\/jbc.C400060200","volume":"279","author":"B Mangeat","year":"2004","unstructured":"Mangeat B, Turelli P, Liao S, Trono D: A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action. J Biol Chem. 2004, 279: 14481-14483. 10.1074\/jbc.C400060200.","journal-title":"J Biol Chem"},{"key":"89_CR31","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.1073\/pnas.0307132101","volume":"101","author":"B Schrofelbauer","year":"2004","unstructured":"Schrofelbauer B, Chen D, Landau NR: A single amino acid of APOBEC3G controls its species-specific interaction with virion infectivity factor (Vif). Proc Natl Acad Sci U S A. 2004, 101: 3927-3932. 10.1073\/pnas.0307132101.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"89_CR32","doi-asserted-by":"crossref","first-page":"9358","DOI":"10.1128\/jvi.71.12.9358-9365.1997","volume":"71","author":"M Bouyac","year":"1997","unstructured":"Bouyac M, Courcoul M, Bertoia G, Baudat Y, Gabuzda D, Blanc D, Chazal N, Boulanger P, Sire J, Vigne R, Spire B: Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor. J Virol. 1997, 71: 9358-9365.","journal-title":"J Virol"},{"key":"89_CR33","doi-asserted-by":"crossref","unstructured":"Strebel K, Khan MA: APOBEC3G encapsidation into HIV-1 virions: which RNA is it?Retrovirology 2008, 5:55.,","DOI":"10.1186\/1742-4690-5-55"},{"key":"89_CR34","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1128\/jvi.65.4.1779-1788.1991","volume":"65","author":"JP Vartanian","year":"1991","unstructured":"Vartanian JP, Meyerhans A, Asjo B, Wain-Hobson S: Selection, recombination, and G--A hypermutation of human immunodeficiency virus type 1 genomes. J Virol. 1991, 65: 1779-1788.","journal-title":"J Virol"},{"key":"89_CR35","doi-asserted-by":"publisher","first-page":"7973","DOI":"10.1128\/JVI.75.17.7973-7986.2001","volume":"75","author":"M Janini","year":"2001","unstructured":"Janini M, Rogers M, Birx DR, McCutchan FE: Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol. 2001, 75: 7973-7986. 10.1128\/JVI.75.17.7973-7986.2001.","journal-title":"J Virol"},{"key":"89_CR36","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1128\/JVI.79.3.1975-1980.2005","volume":"79","author":"TL Kieffer","year":"2005","unstructured":"Kieffer TL, Kwon P, Nettles RE, Han Y, Ray SC, Siliciano RF: G- > A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo. J Virol. 2005, 79: 1975-1980. 10.1128\/JVI.79.3.1975-1980.2005.","journal-title":"J Virol"},{"key":"89_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.virol.2008.03.017","volume":"376","author":"GH Kijak","year":"2008","unstructured":"Kijak GH, Janini LM, Tovanabutra S, Sanders-Buell E, Arroyo MA, Robb ML, Michael NL, Birx DL, McCutchan FE: Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells. Virology. 2008, 376: 101-111. 10.1016\/j.virol.2008.03.017.","journal-title":"Virology"},{"key":"89_CR38","doi-asserted-by":"publisher","first-page":"7805","DOI":"10.1128\/JVI.00280-09","volume":"83","author":"A Piantadosi","year":"2009","unstructured":"Piantadosi A, Humes D, Chohan B, McClelland RS, Overbaugh J: Analysis of the percentage of human immunodeficiency virus type 1 sequences that are hypermutated and markers of disease progression in a longitudinal cohort, including one individual with a partially defective Vif. J Virol. 2009, 83: 7805-7814. 10.1128\/JVI.00280-09.","journal-title":"J Virol"},{"key":"89_CR39","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.virol.2006.10.036","volume":"360","author":"H Xu","year":"2007","unstructured":"Xu H, Chertova E, Chen J, Ott DE, Roser JD, Hu WS, Pathak VK: Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions. Virology. 2007, 360: 247-256. 10.1016\/j.virol.2006.10.036.","journal-title":"Virology"},{"key":"89_CR40","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1074\/jbc.M607298200","volume":"282","author":"RK Holmes","year":"2007","unstructured":"Holmes RK, Koning FA, Bishop KN, Malim MH: APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G. J Biol Chem. 2007, 282: 2587-2595. 10.1074\/jbc.M607298200.","journal-title":"J Biol Chem"},{"key":"89_CR41","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cub.2004.12.068","volume":"15","author":"EN Newman","year":"2005","unstructured":"Newman EN, Holmes RK, Craig HM, Klein KC, Lingappa JR, Malim MH, Sheehy AM: Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity. Curr Biol. 2005, 15: 166-170. 10.1016\/j.cub.2004.12.068.","journal-title":"Curr Biol"},{"key":"89_CR42","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.1128\/jvi.69.11.7196-7204.1995","volume":"69","author":"J Goncalves","year":"1995","unstructured":"Goncalves J, Shi B, Yang X, Gabuzda D: Biological activity of human immunodeficiency virus type 1 Vif requires membrane targeting by C-terminal basic domains. J Virol. 1995, 69: 7196-7204.","journal-title":"J Virol"},{"key":"89_CR43","doi-asserted-by":"crossref","unstructured":"Kao S, Miyagi E, Khan MA, Takeuchi H, Opi S, Goila-Gaur R, Strebel K: Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells.Retrovirology 2004, 1:27.,","DOI":"10.1186\/1742-4690-1-27"},{"key":"89_CR44","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1128\/jvi.66.11.6547-6554.1992","volume":"66","author":"B Chesebro","year":"1992","unstructured":"Chesebro B, Wehrly K, Nishio J, Perryman S: Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: definition of critical amino acids involved in cell tropism. J Virol. 1992, 66: 6547-6554.","journal-title":"J Virol"},{"key":"89_CR45","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","volume":"72","author":"EJ Platt","year":"1998","unstructured":"Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D: Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol. 1998, 72: 2855-2864.","journal-title":"J Virol"},{"key":"89_CR46","doi-asserted-by":"publisher","first-page":"4840","DOI":"10.1128\/JVI.01911-09","volume":"84","author":"Q Shao","year":"2010","unstructured":"Shao Q, Wang Y, Hildreth JE, Liu B: Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif. J Virol. 2010, 84: 4840-4844. 10.1128\/JVI.01911-09.","journal-title":"J Virol"},{"key":"89_CR47","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1371\/journal.ppat.0030135","volume":"3","author":"BK Thielen","year":"2007","unstructured":"Thielen BK, Klein KC, Walker LW, Rieck M, Buckner JH, Tomblingson GW, Lingappa JR: T cells contain an RNase-insensitive inhibitor of APOBEC3G deaminase activity. PLoS Pathog. 2007, 3: 1320-1334. 10.1371\/journal.ppat.0030135.","journal-title":"PLoS Pathog"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-014-0089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12977-014-0089-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-014-0089-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-014-0089-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:05:11Z","timestamp":1630548311000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-014-0089-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,11]]},"references-count":47,"aliases":["10.1186\/preaccept-1021857188124542"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["89"],"URL":"https:\/\/doi.org\/10.1186\/s12977-014-0089-5","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,11]]},"assertion":[{"value":"19 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"89"}}